Cortez Ibdanelo, Denner Larry, Dineley Kelly T
Department of Neurology, The University of Texas Medical Branch at Galveston, Galveston, TX, United States.
Department of Internal Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX, United States.
Front Aging Neurosci. 2019 Mar 14;11:38. doi: 10.3389/fnagi.2019.00038. eCollection 2019.
A major aspect of mammalian aging is the decline in functional competence of many self-renewing cell types, including adult-born neuronal precursors in a process termed neurogenesis. Adult neurogenesis is limited to specific brain regions in the mammalian brain, such as the subgranular zone (SGZ) of the hippocampus. Alterations in adult neurogenesis appear to be a common hallmark in different neurodegenerative diseases including Alzheimer's disease (AD). We and others have shown that PPARγ agonism improves cognition in preclinical models of AD as well as in several pilot clinical trials. Context discrimination is recognized as a cognitive task supported by proliferation and differentiation of adult-born neurons in the dentate gyrus of the hippocampus that we and others have previously shown declines with age. We therefore postulated that PPARγ agonism would positively impact context discrimination in middle-aged mice via mechanisms that influence proliferation and differentiation of adult-born neurons arising from the SGZ. To achieve our objective, 8-months old mice were left untreated or treated with the FDA-approved PPARγ agonist, rosiglitazone then tested for context discrimination learning and memory, followed by immunofluorescence evaluation of hippocampal SGZ cell proliferation and neuron survival. We found that PPARγ agonism enhanced context discrimination performance in middle-aged mice concomitant with stimulated SGZ cell proliferation, but not new neuron survival. Focal cranial irradiation that destroys neurogenesis severely compromised context discrimination in middle-aged mice yet rosiglitazone treatment significantly improved cognitive performance through an anti-inflammatory mechanism and resurrection of the neurogenic niche. Thus, we have evidence for divergent mechanisms by which PPARγ agonism impinges upon aging-related versus cranial irradiation-induced deficits in context discrimination learning and memory.
哺乳动物衰老的一个主要方面是许多自我更新细胞类型的功能能力下降,包括在一个称为神经发生的过程中成年产生的神经元前体。成年神经发生仅限于哺乳动物大脑中的特定脑区,如海马体的颗粒下区(SGZ)。成年神经发生的改变似乎是包括阿尔茨海默病(AD)在内的不同神经退行性疾病的一个共同特征。我们和其他人已经表明,PPARγ激动剂在AD的临床前模型以及一些试点临床试验中可改善认知。情境辨别被认为是一项认知任务,由海马齿状回中成年产生的神经元的增殖和分化所支持,我们和其他人之前已经表明,这种能力会随着年龄的增长而下降。因此,我们推测PPARγ激动剂将通过影响源自SGZ的成年产生的神经元的增殖和分化的机制,对中年小鼠的情境辨别产生积极影响。为了实现我们的目标,对8个月大的小鼠不进行治疗或用FDA批准的PPARγ激动剂罗格列酮进行治疗,然后测试其情境辨别学习和记忆能力,随后对海马SGZ细胞增殖和神经元存活进行免疫荧光评估。我们发现,PPARγ激动剂增强了中年小鼠的情境辨别能力,同时刺激了SGZ细胞增殖,但对新神经元存活没有影响。破坏神经发生的局部颅脑照射严重损害了中年小鼠的情境辨别能力,但罗格列酮治疗通过抗炎机制和神经发生微环境的恢复显著改善了认知能力。因此,我们有证据表明PPARγ激动剂通过不同机制影响与衰老相关的以及颅脑照射诱导的情境辨别学习和记忆缺陷。